Diabetes

News

Lilly soars on first data for oral obesity candidate

Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron.

News

Compounders cast adrift after semaglutide shortage ends

The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.

News

First biosimilar fast-acting insulin reaches US market

Sanofi has claimed FDA approval for the first biosimilar of Novo Nordisk's rapid-acting insulin analogue Novolog.

News

Liva buys Momenta to bolster digital health platform

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Novo rises on Wegovy sales leap, but warns of a slowdown

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

R&D

Pharma holds it breath for ’25 as the sun shines on JP Morga...

The JP Morgan Healthcare Conference is seen as a barometer for the life sciences industry – and, going into this year’s event, the forecast for the year was particularly grim.

Lilly soars on first data for oral obesity candidate

Compounders cast adrift after semaglutide shortage ends

First biosimilar fast-acting insulin reaches US market

Liva buys Momenta to bolster digital health platform

Novo rises on Wegovy sales leap, but warns of a slowdown

Pharma holds it breath for ’25 as the sun shines on JP Morga...

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Diabetes

Editor's Picks